DAXX and ATRX Expression in Canine Prostate and Bladder Cancer Identified by Digital Quantitative Immunohistochemistry
Preprint
- 12 November 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The chromatin remodelling proteins DAXX and ATRX are key regulators of ge-nome stability and epigenetic processes. Alterations in their expression have been as-sociated with tumour stage and prognostic outcomes in various humane cancer types, whereas their role in veterinary oncology has received little investigation to date. We analysed canine prostate and urinary bladder samples, including 18 prostate carcino-mas (12 adenocarcinomas, 6 prostatic urothelial carcinomas), 10 non-malignant pros-tate tissues, 22 carcinomas of the urinary bladder and 6 non-malignant bladder tissues. Nuclear expression of DAXX and ATRX was assessed using fully quantitative digital immunohistochemistry. Overall, DAXX exhibited consistently higher expression than ATRX across benign and malignant samples from the prostate and bladder. DAXX and ATRX expression demonstrated a positive correlation across all prostate (ρ = 0.692, p < 0.05) and bladder (ρ = 0.488, p < 0.05) samples, suggesting coordinated regulation. They displayed organ-specific expression patterns: prostate carcinomas showed increased expression of both proteins compared with non-malignant prostate tissues. In contrast, in the bladder, expression declined with increasing tumour aggressiveness (p < 0.05). Our findings provide new insights into the potential of DAXX and ATRX as bi-omarkers, offering new insights into their clinical relevance in dogs.Keywords
All Related Versions
- Version 1, 2025-11-12, Preprints
- Published version: Veterinary Sciences, 12 (12), 1209.
This publication has 48 references indexed in Scilit:
- Personalized medicine: An alternative for cancer treatmentCancer Treatment and Research Communications, 2024
- Highlighting vulnerabilities in the alternative lengthening of telomeres pathwayCurrent Opinion in Pharmacology, 2023
- Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsEndocrine Pathology, 2022
- The chromatin remodeler complex ATRX-DAXX-H3.3 and telomere length in meningiomasClinical Neurology and Neurosurgery, 2021
- Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinomaVirchows Archiv, 2020
- Alternative lengthening of telomeres does exist in various canine sarcomasMolecular Carcinogenesis, 2016
- Overexpression of the chromatin remodeler death-domain–associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrenceHuman Pathology, 2013
- Interobserver variability in the evaluation of mismatch repair protein immunostainingHuman Pathology, 2010
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- Chromatin Challenges during DNA Replication and RepairCell, 2007